型号：GM-J#027719 -Available

应用：These Piezo2-GFP-IRES-Cre knock-in reporter mice express GFP fused to PIEZO2 as well as cre recombinase from the Piezo2 promoter.

型号：GM-J#027718 -Cryorecovery

应用：These Npas1-tdTom mice express icre and tdTomato in most (approximately 88%) of Npas1-expressing neurons in the brain. They are suitable for use in studies related to the external globus pallidus (GPe) nucleus in the basal ganglia.

型号：GM-J#027681 -Cryorecovery

应用：Hnf1bCreER mice may be useful for generating specific targeted mutations or fate-mapping studies of Hnf1b expressing cells.

型号：GM-J#027651 -Cryorecovery

应用：These Sox10-iCreERT2 mutant mice, carrying a transgene with tamoxifen-inducible optimized (improved) Cre recombinase under the control of the mouse Sox10 (SRY (sex determining region Y)-box 10) promoter, expresses iCreERT2 in oligodendrocyte lineage cells.

型号：GM-J#027630 -Cryorecovery

应用：These wt h-parkin transgenic mice express human parkin (PARK2) in almost all ventral midbrain dopaminergic neurons (at a 7- to 8-fold increase compared to endogenous mouse parkin protein) and may be suitable for use in studies related to neurodegeneration and Parkinson Disease.

型号：GM-J#027524 -Cryorecovery

应用：IL22Cre knock-out/in mice express Cre recombinase in a subset of lymphoid cells including group 3 innate lymphoid cells in the gut and γδ T cells in skin or lung.

型号：GM-J#027406 -Cryorecovery

应用：hCD2-cre mice may be useful for generating conditional mutations in mature CD4+ and CD8+ T cells.

型号：GM-J#027400 -Cryorecovery

应用：These R4Ag11 mice express nuclear-localized Cre recombinase from the mouse Camk2a promoter in the adult brain, with high levels in the forebrain.

型号：GM-J#027310 -Cryorecovery

应用：These R1Ag5 (R1ag#5) mice express nuclear-localized Cre recombinase from the mouse Camk2a promoter in the adult brain, with high levels in all forebrain structures, and moderate levels in the cerebellum as well as testis.

型号：GM-J#027235 -Cryorecovery

应用：The tamoxifen-inducible Notch1 activation-dependent reporter knock-in allele, N1IP::CreERT2, has the endogenous Notch1 intracellular domain (NICD1) replaced with a 6xMyc-tagged, tamoxifen-inducible Cre recombinase (6mtCreERT2). Similar to the N1IP::CreLO allele, this N1IP::CreERT2 allele is predominantly expressed in cells in which moderate-to-high levels of sustained Notch activity or repeated activation cycles are known to occur (e.g., endothelium), with the added benefit that Cre recombinase activity is tamoxifen-inducible.